| dc.contributor.author | Amariles Muñoz, Pedro | |
| dc.contributor.author | Machuca González, Manuel | |
| dc.contributor.author | Faus Dader, María José | |
| dc.contributor.author | Baena, María Isabel | |
| dc.contributor.author | Martínez-Martínez, Fernando | |
| dc.contributor.author | Jiménez-Martín, José | |
| dc.date.accessioned | 2024-01-18T09:37:32Z | |
| dc.date.available | 2024-01-18T09:37:32Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Amariles P, Machuca M, Faus MJ, Baena MI, Martinez-Martinez F, Jimenez-Martin J. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies. J Clin Pharm Ther. 2008 Oct;33(5):475-81. doi: 10.1111/j.1365-2710.2008.00953.x. PMID: 18834361. | es |
| dc.identifier.issn | 0269-4727 | |
| dc.identifier.issn | 1365-2710 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12412/4937 | |
| dc.description.abstract | The assessment and follow-up of
patients with risk factors, or with cardiovascular
disease (CVD), involves estimating andmonitoring
their CVD risk (CVDR). There are different opinions
about the most appropriate method for this.
Objective: To compare the SCORE system and the
Wilson–Grundy system (based on Framingham’s
study).The cardiovascular risk of patients
that attend community pharmacies with prescriptions
for cardiovascular medications is significantly
higher when assessed using the SCORE
system than with the Wilson–Grundy method. | es |
| dc.language.iso | eng | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Application of the SCORE and Wilson–Grundy methods for the assessment of cardiovascular risk in community pharmacies. | es |
| dc.type | article | es |
| dc.identifier.doi | 10.1111/j.1365-2710.2008.00953.x | |
| dc.issue.number | 5 | es |
| dc.journal.title | Journal of Clinical Pharmacy and Therapeutics | es |
| dc.page.initial | 475 | es |
| dc.page.final | 481 | es |
| dc.rights.accessRights | openAccess | es |
| dc.subject.keyword | Cardiovascular disease risk | es |
| dc.subject.keyword | Community pharmacy | es |
| dc.subject.keyword | Pharmacotherapeutic follow-up | es |
| dc.subject.keyword | SCORE system | es |
| dc.subject.keyword | Wilson-Grundy method | es |
| dc.volume.number | 33 | es |